Posted 29 August, 2022
PaxMedica, Inc. IPO completed
IPO completed detected for ticker Nasdaq:PXMD in a 424B4 filed on 29 August, 2022.
This is the initial public offering of PaxMedica, Inc. We are offering 1,545,454 shares of our common stock in this offering.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of PaxMedica, Inc.
Health Care/Life Sciences • Biotechnology
PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.Market Cap
$3.08M
View Company Details
$3.08M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.